BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15705407)

  • 1. Evaluation of serum androgen levels in women with premature ovarian failure.
    Benetti-Pinto CL; Bedone AJ; Magna LA
    Fertil Steril; 2005 Feb; 83(2):508-10. PubMed ID: 15705407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum androgens concentrations in women with idiopathic premature ovarian failure].
    Skałba P; Bednarska-Czerwińska A; Wójtowicz M; Lewandowski P
    Wiad Lek; 2006; 59(1-2):52-7. PubMed ID: 16646293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undetectable salivary testosterone in young women with premature ovarian failure.
    Mason A; Wallace AM; Macintyre H; Teoh YP; Bath LE; Critchley HO; Kelnar CJ; Wallace WH; Ahmed SF
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):711-4. PubMed ID: 16712676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women.
    Bell RJ; Donath S; Davison SL; Davis SR
    Menopause; 2006; 13(1):65-71. PubMed ID: 16607100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P; Wójtowicz M; Sikora J
    Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profile of women with premature ovarian failure.
    Knauff EA; Westerveld HE; Goverde AJ; Eijkemans MJ; Valkenburg O; van Santbrink EJ; Fauser BC; van der Schouw YT
    Menopause; 2008; 15(5):919-23. PubMed ID: 18551082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
    Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
    Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction.
    Guay A; Jacobson J; Munarriz R; Traish A; Talakoub L; Quirk F; Goldstein I; Spark R
    Int J Impot Res; 2004 Apr; 16(2):121-9. PubMed ID: 14973532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis.
    Soman M; Huang LC; Cai WH; Xu JB; Chen JY; He RK; Ruan HC; Xu XR; Qian ZD; Zhu XM
    Menopause; 2019 Jan; 26(1):78-93. PubMed ID: 29994966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GVHD and receiving glucocorticoid therapy.
    Hovi L; Saarinen-Pihkala UM; Taskinen M; Wikström AM; Dunkel L
    Bone Marrow Transplant; 2004 Mar; 33(5):503-8. PubMed ID: 14716348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of androgens in women.
    Stanczyk FZ
    Semin Reprod Med; 2006 Apr; 24(2):78-85. PubMed ID: 16633981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levels of androgen in serum in female acne patients.
    Schmidt JB; Spona J
    Endocrinol Exp; 1985 Mar; 19(1):17-23. PubMed ID: 3157562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between reproductive and menstrual factors and postmenopausal androgen concentrations.
    Chubak J; Tworoger SS; Yasui Y; Ulrich CM; Stanczyk FZ; McTiernan A
    J Womens Health (Larchmt); 2005 Oct; 14(8):704-12. PubMed ID: 16232102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH; Härle P; Yamana S; Matsuda T; Takasugi K; Kishimoto T; Nishimoto N
    Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure.
    van der Stege JG; Groen H; van Zadelhoff SJ; Lambalk CB; Braat DD; van Kasteren YM; van Santbrink EJ; Apperloo MJ; Weijmar Schultz WC; Hoek A
    Menopause; 2008; 15(1):23-31. PubMed ID: 18257141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in women with idiopathic premature ovarian failure.
    Munz W; Hammadeh ME; Seufert R; Schaffrath M; Schmidt W; Pollow K
    Fertil Steril; 2004 Sep; 82(3):760-2. PubMed ID: 15374731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.